Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients

NCT00494949 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypotension
Hypoxia

Interventions

DRUG: Hemospan (MP4OX)
DRUG: Ringer's lactate

Sponsor

Sangart